Lymphedema following cancer therapy

overview and options

Michael J Bernas, Saskia R.J. Thiadens, Betty Smoot, Jane M. Armer, Paula Stewart, Jay Granzow

Research output: Contribution to journalArticle

Abstract

This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to highlight what is known and more importantly what is unknown about the current state of research and treatment in the United States. The session opened with an introduction to lymphedema and then explored the incidence of multiple cancer-related lymphedemas, imaging tools and techniques useful for the diagnosis of lymphatic system abnormalities, and the new findings concerning the genetics of cancer-related lymphedema. It closed with a review of advocacy for patients and healthcare professionals and both conservative and surgical treatment options, followed by a panel discussion and questions. The session provided important information and updates which will be of value for improving the rehabilitation and overall support of patients with cancer-related lymphedema.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalClinical and Experimental Metastasis
DOIs
StateAccepted/In press - May 17 2018
Externally publishedYes

Fingerprint

Lymphedema
Neoplasms
Lymphatic Abnormalities
Therapeutics
Delivery of Health Care
Patient Advocacy
Lymphatic System
Rehabilitation
Research Personnel
Neoplasm Metastasis
Physicians
Incidence
Research

Keywords

  • Advocacy
  • Diagnosis
  • Genetics
  • Imaging
  • Lymphedema
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bernas, M. J., Thiadens, S. R. J., Smoot, B., Armer, J. M., Stewart, P., & Granzow, J. (Accepted/In press). Lymphedema following cancer therapy: overview and options. Clinical and Experimental Metastasis, 1-5. https://doi.org/10.1007/s10585-018-9899-5

Lymphedema following cancer therapy : overview and options. / Bernas, Michael J; Thiadens, Saskia R.J.; Smoot, Betty; Armer, Jane M.; Stewart, Paula; Granzow, Jay.

In: Clinical and Experimental Metastasis, 17.05.2018, p. 1-5.

Research output: Contribution to journalArticle

Bernas, Michael J ; Thiadens, Saskia R.J. ; Smoot, Betty ; Armer, Jane M. ; Stewart, Paula ; Granzow, Jay. / Lymphedema following cancer therapy : overview and options. In: Clinical and Experimental Metastasis. 2018 ; pp. 1-5.
@article{4b5efc2bc06340f1a0821564b843f5ba,
title = "Lymphedema following cancer therapy: overview and options",
abstract = "This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to highlight what is known and more importantly what is unknown about the current state of research and treatment in the United States. The session opened with an introduction to lymphedema and then explored the incidence of multiple cancer-related lymphedemas, imaging tools and techniques useful for the diagnosis of lymphatic system abnormalities, and the new findings concerning the genetics of cancer-related lymphedema. It closed with a review of advocacy for patients and healthcare professionals and both conservative and surgical treatment options, followed by a panel discussion and questions. The session provided important information and updates which will be of value for improving the rehabilitation and overall support of patients with cancer-related lymphedema.",
keywords = "Advocacy, Diagnosis, Genetics, Imaging, Lymphedema, Treatment",
author = "Bernas, {Michael J} and Thiadens, {Saskia R.J.} and Betty Smoot and Armer, {Jane M.} and Paula Stewart and Jay Granzow",
year = "2018",
month = "5",
day = "17",
doi = "10.1007/s10585-018-9899-5",
language = "English (US)",
pages = "1--5",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Lymphedema following cancer therapy

T2 - overview and options

AU - Bernas, Michael J

AU - Thiadens, Saskia R.J.

AU - Smoot, Betty

AU - Armer, Jane M.

AU - Stewart, Paula

AU - Granzow, Jay

PY - 2018/5/17

Y1 - 2018/5/17

N2 - This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to highlight what is known and more importantly what is unknown about the current state of research and treatment in the United States. The session opened with an introduction to lymphedema and then explored the incidence of multiple cancer-related lymphedemas, imaging tools and techniques useful for the diagnosis of lymphatic system abnormalities, and the new findings concerning the genetics of cancer-related lymphedema. It closed with a review of advocacy for patients and healthcare professionals and both conservative and surgical treatment options, followed by a panel discussion and questions. The session provided important information and updates which will be of value for improving the rehabilitation and overall support of patients with cancer-related lymphedema.

AB - This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to highlight what is known and more importantly what is unknown about the current state of research and treatment in the United States. The session opened with an introduction to lymphedema and then explored the incidence of multiple cancer-related lymphedemas, imaging tools and techniques useful for the diagnosis of lymphatic system abnormalities, and the new findings concerning the genetics of cancer-related lymphedema. It closed with a review of advocacy for patients and healthcare professionals and both conservative and surgical treatment options, followed by a panel discussion and questions. The session provided important information and updates which will be of value for improving the rehabilitation and overall support of patients with cancer-related lymphedema.

KW - Advocacy

KW - Diagnosis

KW - Genetics

KW - Imaging

KW - Lymphedema

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85047124545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047124545&partnerID=8YFLogxK

U2 - 10.1007/s10585-018-9899-5

DO - 10.1007/s10585-018-9899-5

M3 - Article

SP - 1

EP - 5

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

ER -